Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00631111 · ClinicalTrials.gov registry record · Phase 3
Study Evaluating the Efficacy of an Ibuprofen Effervescent Tablet in the Treatment of Post-Surgical Dental Pain
A Phase 3 study, sponsored by Wyeth is now a wholly owned subsidiary of Pfizer.
- Completed
- Registry status
- Phase 3
- Development phase
- 270
- Enrollment target
NCT00631111 is a Phase 3 study that has completed, run by Wyeth is now a wholly owned subsidiary of Pfizer. The registered enrollment target is 270 participants.
The verdict
NCT00631111, a Phase 3 study, has completed, sponsored by Wyeth is now a wholly owned subsidiary of Pfizer.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 270 participants
- Enrollment target
Study Summary
Evaluation of the efficacy and safety of a single dose of an ibuprofen effervescent tablet in the treatment of pain following third molar extraction in comparison to single doses of placebo, standard ibuprofen tablets, and effervescent aspirin plus vitamin C tablets.
Interventions
- DRUG placebo
- DRUG effervescent ibuprofen tablets
- DRUG effervescent Aspirin plus Vitamin C tablets
- DRUG ibuprofen tablets
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 270 participants |
| Start Date | 2007-11 |
| Est. Completion | 2008-04 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00631111
The ClinicalTrials.gov registry entry for NCT00631111 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 270 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wyeth is now a wholly owned subsidiary of Pfizer, which has 167 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which placebo is the first listed.
NCT00631111 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00631111 about?
NCT00631111 is a clinical study titled "Study Evaluating the Efficacy of an Ibuprofen Effervescent Tablet in the Treatment of Post-Surgical Dental Pain". Evaluation of the efficacy and safety of a single dose of an ibuprofen effervescent tablet in the treatment of pain following third molar extraction in comparison to single doses of placebo, standard ibuprofen tablets, and effervescent aspirin plus vitamin C tablets.
What is the current status of trial NCT00631111?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 270 participants. The study started on 2007-11. Estimated completion is 2008-04.
What interventions are being tested in trial NCT00631111?
The interventions under investigation include: placebo (DRUG), effervescent ibuprofen tablets (DRUG), effervescent Aspirin plus Vitamin C tablets (DRUG), ibuprofen tablets (DRUG).
Who is sponsoring clinical trial NCT00631111?
This trial is sponsored by Wyeth is now a wholly owned subsidiary of Pfizer, which has 167 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.